Agree to disagree then. (I feel like I'm just banging my head into the wall at this point).
You're focusing on a specific anomaly (i.e. the rare event that a provider didn't remove all of a maligant lesions (e.g., BCC, SCC, melanoma, merkel cell, etc.). By the end of the postop period, after path has returned and reviewed, it should be known at this point. If during this E/M visit after postop has ended (again, per the original question) it's determined that the tumor is still present or wasn't completely removed, the patient would still have this condition and it would be appropriately coded as so.
But for all intents and purposes, after removal (excision, Mohs, etc.), and absent any indications via path, dermatologists handle this as previously treated condition, not an active condition. You don't code a condition that is no longer present. Therefore, personal history codes are used. Been this way forever in the world of dermatology.
My position is backed by the ICD-10 guidelines and the AAD. After 25 years of educating providers, billing claims, and coding professionally, I'll stand by it.